United States Anesthesia Drugs Market & Forecast
Browse Full Report @
Published: Dec 2014| No. Of Pages: 74 Pages
PDF: $ 1450 | CD : $ 1550 | Hard copy : $ 1550 |Site Licence : $ 2100 | Enterprise Wide Licence : $ 2100
Anesthesia drugs are used during tests and surgical operations to induce sleep, which prevents pain and discomfort and enables a wide range of medical procedures to be performed. Local Anesthesia and General Anesthesia are the two commonly used types of anesthesia. Local anesthesia is a condition when sensation within a specific body part in inhibited, where as general anesthesia results in loss of consciousness and sensation.
United States anesthesia drugs market is expected to be more than US$ 3 Billion by 2018. General Intravenous
Anesthesia drugs market is dominating the United States anesthesia drugs market. In further classification of General
Intravenous Anesthesia Drugs market, Propofol and Benzodiazepines Class (Diazepam and Midazolam) are the top
contributors to intravenous anesthetic drugs in the United States anesthesia drugs market. In classification of Local
Anesthesia Drugs Market Share Lidocaine holds the maximum market share. From companies analysis part Baxter
International Inc, Endo Health Solutions Inc and Abbott Laboratories are three main players, but Others companies also play a major role in United States anesthesia drugs market.
Renub Research report titled ""United States Anesthesia Drugs Market & Forecast” provides a comprehensive analysis of the current state of this market and likely future evolution over the next 5 years. This 74 page report with 56 Figures and 1 Table provides a complete analysis of local and general anesthesia drugs market in United States. This report has been studied from 2 viewpoints.
1. General Anesthesia Drugs Market
2. Local Anesthesia Drugs...